1 1

HealthCert Education

Introduction to the Endocannabinoid System

Introduction to the Endocannabinoid System

Unlock the complexities of the endocannabinoid system with this foundational course designed for healthcare professionals. Explore the system's role in maintaining homeostasis, including its impact on pain management, mood regulation, energy balance, and stress coping. Gain insights into key components like endocannabinoids, receptors, and enzymes, as well as therapeutic applications of cannabinoids like THC and CBD. With a focus on evidence-based learning, this course equips you with the knowledge to understand how targeting the endocannabinoid system can influence various health conditions and improve patient outcomes.

time-icon 4.0 hrs EA | 5.0 hrs RP | 0.0 hrs OM
$195.00
$195.00
Sale Sold out

SHOP-P2CBD

View full details

  • FLEXIBLE TIMING

  • 100% ONLINE

  • accredited Course

  • Expert instructor

The Introduction to the Endocannabinoid System course provides a comprehensive exploration of the naturally occurring lipid signaling system that plays a vital role in regulating physiological functions and maintaining homeostasis. Presented by A/Prof Jonathan Arnold, a leading expert in cannabinoid pharmacology, this course delivers cutting-edge insights into one of the body's most fascinating systems.

This unit delves into the foundational aspects of the endocannabinoid system, covering its structure, function, and therapeutic potential. Key topics include:
- Components of the Endocannabinoid System:
- Endocannabinoids: Anandamide and 2-AG, their synthesis, and degradation.
- Cannabinoid Receptors (CB1 and CB2): Their distribution, roles, and interaction with various physiological processes.
- Enzymes: Key synthetic and catabolic enzymes regulating endocannabinoid levels.

- Functions and Mechanisms:
- Homeostatic roles in analgesia, mood, energy balance, and stress response.
- Retrograde signaling in the brain, modulating neurotransmitter release to maintain cellular balance.
- Extended interactions with other receptors and pathways, including TRPV1 channels and PPARs.

- Therapeutic Implications:
- Relationship between endocannabinoid dysregulation and conditions like chronic pain, epilepsy, PTSD, and neurodegenerative diseases.
- Overview of cannabinoids (THC, CBD) and their mimicking of endocannabinoid actions.
- Insights into synthetic cannabinoids and their development as therapeutic agents.

- Research and Innovations:
- Cutting-edge discoveries, including enzyme inhibitors and positive allosteric modulators.
- Case studies illustrating the system's impact on diseases like Dravet syndrome and Huntington’s disease.

This course equips healthcare professionals with a deep understanding of the endocannabinoid system's pivotal role in health and disease. By integrating theoretical knowledge with real-world applications, participants will gain the skills to explore its potential in therapeutic contexts, ultimately enhancing patient care.

  1. Distinguish the Endocannabinoid system and its interaction with other body systems.
  2. Determine the functions of the Endocannabinoid system.

This course is designed for GPs and is also suitable for all degree qualified medical professionals.

cpd hours image

CPD Hours:

  • Education hours:  4.0
  • Reviewing performance hours: 5.0
  • Measuring outcome hours:  0.0
cpd hours image

Accreditations:

Royal Australian College of General Practice (RACGP) #411966

Australian College of Rural and Remote Medicine (ACRRM) #30966

cpd hours image

Study Mode:

100% online

cpd hours image

Study duration:

9.0 hrs self-paced

cpd hours image

ABOUT THE PRESENTER

A/Prof Jonathan Arnold

This course is presented by A/Prof Jonathan Arnold.

He is a world leader in the science of cannabis and the cannabinoids. He is Deputy Academic Director of the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney, Australia. This is a cross faculty research initiative that specialises in the discovery and development of cannabis-based medicines. In 2018 he was one of four scientists selected to advise the World Health Organisation (WHO) on their historical review of cannabis and the cannabinoids. A/Prof Arnold has over 20 years’ experience in cannabinoid pharmacology and has published extensively on the molecular, cellular, neurobiological and behavioural actions of the phytocannabinoids, cannabidiol (CBD) and tetrahydrocannabinol (THC).